-
One-step TUNEL Cy3 Apoptosis Detection Kit Guide
2026-10-02
This practical guide shows how to apply Cy3-based TUNEL labeling across tissue sections, adherent cells, suspension cells, and combination-treatment studies. It also explains how to interpret DNA fragmentation alongside pyroptosis markers so that a positive signal is not mistaken for proof of one specific death pathway.
-
Mechanism-Ready Genotyping for Translational Research
2026-10-01
Mechanistic biology becomes translationally useful only when genotype, phenotype, and workflow quality remain connected. This article examines the NR1I3–E-cadherin findings in experimental colitis and shows how rapid, single-tube genotyping can strengthen model validation across tissues, fishes, insects, and cells.
-
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-10-01
Oliveira et al. show that naturally occurring angiotensin peptides can alter SARS-CoV-2 spike-protein binding to host receptors, with the strongest effects observed for shorter or N-terminally modified peptides and the AXL receptor. The work connects renin-angiotensin system peptide processing with viral receptor engagement while also defining important limits: the study measured binding in antibody-based assays rather than viral entry or disease outcomes.
-
Asunaprevir Workflow for HCV Research
2026-09-30
Build reproducible HCV protease and cellular replication studies around nanomolar Asunaprevir (BMS-650032), with genotype-aware controls and solvent-safe dosing. The workflow also adapts a high-throughput reporter-screen principle from NUT carcinoma research without confusing assay design lessons with evidence of anticancer activity.
-
GRE Combination Inhibits Melanogenesis via CREB/MITF
2026-09-30
The reference study shows that glabridin, resveratrol, and ellagic acid form a high-performing combination for suppressing melanin production, oxidative stress, and inflammatory signaling in cell-based assays. Its mechanistic contribution is the linkage of reduced melanogenesis with inhibition of CREB phosphorylation and MITF-associated gene and protein expression, while also providing a practical multi-endpoint framework for pigmentation regulation research.
-
REV1–DHX36 Control of G-Quadruplex Replication
2026-09-29
The reference study identifies a direct REV1–DHX36 partnership that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its two-tier model explains how REV1 deficiency increases G4-associated replication stress, mutagenesis, and ATM/ATR signaling, while providing a mechanistic framework for genome-integrity and cancer research.
-
Dabigatran: A Metabolite-Aware Assay Strategy
2026-09-29
Dabigatran is more than a potent thrombin blocker: its active acylglucuronide metabolite can change how anticoagulant assays should be designed and interpreted. This guide translates comparative evidence into a metabolite-aware workflow for thrombin inhibition assays and coagulation function tests.
-
5X Protein Loading Buffer (Reducing): Practical Guide
2026-09-28
5X Protein Loading Buffer (Reducing) prepares protein samples for denaturing, reducing SDS-PAGE, helping standardize sample loading and molecular-weight separation. Use it when disulfide bonds should be reduced; do not use it for native analysis or experiments that require non-reducing disulfide patterns.
-
HotStart™ 2X Green qPCR Master Mix for Cell Assays
2026-09-27
A scenario-led guide to using HotStart™ 2X Green qPCR Master Mix (SKU K1070) alongside cell viability, proliferation, and cytotoxicity experiments. Learn where SYBR Green qPCR can clarify gene-expression changes, how to reduce avoidable amplification artifacts, and what to check when selecting a master mix.
-
Ziprasidone HCl: Mechanisms and Research Evidence
2026-09-26
Ziprasidone HCl is a second-generation antipsychotic compound with established dopamine and serotonin receptor pharmacology and reported GOT1-inhibitory activity in cancer research. This evidence review separates product-reported laboratory benchmarks from clinical findings and outlines the limits of translating them across research domains.
-
RAB31 Defines an ESCRT-Independent Exosome Route
2026-09-26
The study identifies RAB31 as a regulator of an exosome pathway that can form intraluminal vesicles independently of ESCRT machinery. RAB31 works with flotillin proteins to promote vesicle formation and recruits TBC1D2B to restrain RAB7-dependent lysosomal fusion, linking cargo sorting to the fate of multivesicular endosomes.
-
Pirfenidone in Pulmonary Fibrosis Research
2026-09-25
Use Pirfenidone as a pathway-aware antifibrotic benchmark to connect inflammatory, TGF-β, and matrix-remodeling readouts in pulmonary fibrosis models. Pair it with the recent worenine findings to distinguish shared fibrosis phenotypes from compound-specific signaling, without assuming a shared mechanism.
-
Munc18c–Syntaxin4 Control of Tumor Cell Invasion
2026-09-25
Brasher and colleagues identify Munc18c as a regulator of syntaxin4-dependent invadopodium formation, linking SNARE-complex regulation to delivery of MT1-MMP and EGFR at the cell surface. Their perturbation experiments support a role for this trafficking pathway in extracellular-matrix invasion in vitro, while leaving its contribution to metastasis in vivo for future study.
-
Persistent rDNA Damage Triggers PML-Nucleolar Compartments
2026-09-24
Urbancokova, Hornofova and colleagues show that topological stress and RNA polymerase I inhibition can create persistent ribosomal DNA lesions associated with PML-nucleolar compartments (PNAs). Their experiments link these compartments to damaged rDNA and an incomplete homologous-recombination response, offering a framework for studying nucleolar genome maintenance and cellular senescence.
-
Amphotericin B: Membrane Assay Workflows
2026-09-24
Build reproducible fungal membrane assays with practical dose selection, vehicle controls, and troubleshooting for Amphotericin B. A classic protoplast study offers a useful membrane-assay design principle—but not direct evidence about this antifungal’s activity.